Apellis Pharmaceuticals buy Saftman
Start price
17.03.23
/
50%
€57.93
Target price
17.03.24
-
Performance (%)
3.57%
End price
31.01.24
€60.00
Summary
This prediction ended on 31.01.24 with a price of €60.00. With a performance of 3.57%, the BUY prediction by Saftman for Apellis Pharmaceuticals closed with a slight gain. Saftman has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | 2.291% | 2.984% | 20.344% |
iShares Nasdaq 100 | 1.336% | -0.196% | 25.550% |
iShares Nikkei 225® | 1.132% | 2.488% | 13.163% |
iShares S&P 500 | 1.272% | 1.334% | 24.544% |
Comments by Saftman for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Saftman hat das Wertpapier Apellis Pharmaceuticals in seinem Wikifolio Langfristige Aufwärtstrends gekauft.